Total planned funding: $385,871,375
Clear active filters
Zimbabwe
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Zimbabwe | $385,871,375 |
Organizational Types
Private Contractor | $115,986,489 |
NGO | $103,505,473 |
Unknown | $79,588,001 |
Own Agency | $40,747,453 |
Implementing Agency | $22,473,433 |
University | $9,288,385 |
Other USG Agency | $6,993,000 |
FBO | $6,039,141 |
Host Country Government Agency | $1,200,000 |
Multi-lateral Agency | $50,000 |
Program Areas
Treatment | $137,860,380 |
Prevention | $98,299,488 |
Care | $64,983,156 |
Testing | $30,961,307 |
Governance and Systems | $27,740,868 |
Management and Operations | $26,026,176 |
Budget Codes
HTXD: Treatment: ARV Drugs | $71,860,127 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $65,162,083 |
HTXS: Treatment: Adult Treatment | $60,703,387 |
HKID: Care: Orphans and Vulnerable Children | $33,478,600 |
HVCT: Testing: HIV Testing and Counseling | $30,961,307 |
HVMS: Management and Operations | $26,026,176 |
HBHC: Care: Adult Care and Support | $17,798,305 |
OHSS: Health Systems Strengthening | $13,901,398 |
HVOP: Sexual Prevention: Other Sexual Prevention | $11,998,062 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $11,443,895 |
HVTB: Care: TB/HIV | $9,355,863 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $8,770,448 |
HVSI: Strategic Information | $8,167,743 |
HLAB: Laboratory Infrastructure | $5,671,727 |
PDTX: Treatment: Pediatric Treatment | $5,296,866 |
PDCS: Care: Pediatric Care and Support | $4,350,388 |
HMBL: Biomedical Prevention: Blood Safety | $825,000 |
HMIN: Biomedical Prevention: Injection Safety | $100,000 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Not Available:
$80,478,001
Countries/Regions
USG Aggregated Agencies:
$35,836,103
Countries/Regions
University of Washington:
$29,791,857
Countries/Regions